FDA to Reassess Ebvallo After Unexpected Rejection
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.
Latest Health stories from Life.
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.
A recent report indicates a steady increase in hospital shootings since 2000, highlighting a troubling trend in healthcare safety and security.
In a significant move within the pharmaceutical industry, Angelini Pharma has announced its acquisition of Catalyst Pharmaceuticals, a company specializing in treatments for rare diseases, for $4.1 billion.
Public health experts express alarm not over the MV Hondius cruise ship as a pandemic threat, but due to insufficient research on hantaviruses.
In response to significant local opposition and potential legal challenges, PeaceHealth has decided not to proceed with its plan to replace Eugene Emergency Physicians with ApolloMD.
The Trump administration's recent actions regarding drug policy appear inconsistent, as the White House endorses treatment methods while imposing new restrictions.
As discussions around pharmaceutical pricing evolve, the 'Most Favored Nation' model emerges as a potential solution worth considering for its implications and benefits.
In a notable move, Sanofi has requested the FDA to withdraw its type 1 diabetes drug from the expedited review process, citing political interference as a key factor.
Color Health is broadening its services to include cancer care coordination, aiming to fill a significant void in the healthcare landscape.
Marty Makary shares his initial doubts regarding flavored vapes but points to the potential of age-gating technology to mitigate risks.
A collaborative effort by researchers worldwide has uncovered thousands of mini-proteins, some linked to critical processes like cell division and DNA repair, with implications for cancer research.
An overview of the ongoing decisions regarding Medicaid expansion in various states under the Affordable Care Act, highlighting the latest developments.
Brittany Trang highlights a potential shift in the dialogue surrounding AI in health care, suggesting that discussions may be moving beyond initial hype.
Recent developments regarding Novo Nordisk's Wegovy pill have led to an uptick in the company's earnings and share price, alongside other notable biotech news.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has launched a substantial ad campaign aimed at the 340B drug discount program, highlighting its budget and focus.
The Supreme Court is set to review Louisiana's challenge against the FDA regarding mifepristone, a case that underscores the contentious legal landscape surrounding abortion rights in the U.S.
As artificial intelligence becomes increasingly integrated into healthcare claims processes, this discussion highlights the importance of consumer protections at both federal and state levels.
KFF has unveiled an interactive dashboard that monitors public trust in health information sources and explores attitudes toward vaccines, reflecting current trends.
A recent KFF Health Tracking Poll indicates that MAHA voters are placing significant emphasis on reducing health care costs, overshadowing other health concerns.
A recent study raises questions about AI's effectiveness in diagnosis, alongside discussions on telehealth's impact on abortion access and an ongoing lawsuit involving Epic.